Amersin Appoints Director
17 nov. 2005 12h21 HE
|
Amersin Life Sciences Corp.
NEW YORK, Nov. 17, 2005 (PRIMEZONE) -- Amersin Life Science Corporation (OTCBB:AMLS) (Frankfurt:HUQ) is pleased to announce the immediate appointment of Mr. Rob Gillingham to its Board of...
Amersin Enters Into Termination Agreement With Chinese Joint Venture Partner
20 oct. 2005 16h30 HE
|
Amersin Life Sciences Corp.
NEW YORK, Oct. 20, 2005 (PRIMEZONE) -- Amersin Life Science Corporation (OTCBB:AMLSE) announced today that it has reached a termination agreement and will be disposing of its interest in the Hubei...
Amersin Notifies Chinese Joint Venture That it Will Not be Providing Additional Funds
15 sept. 2005 17h56 HE
|
Amersin Life Sciences Corp.
NEW YORK, Sept. 15, 2005 (PRIMEZONE) -- Amersin Life Science Corporation (OTCBB:AMLS) Chief Executive Officer, H.Y. (Reid) Li, announced that the company notified the minority partners in its Hubei...
Amersin Announces Delay in Filing Annual Report Due to Auditor's Workload
18 mai 2005 09h30 HE
|
Amersin Life Sciences Corp.
NEW YORK, May 18, 2005 (PRIMEZONE) -- Amersin Life Science Corporation (OTCBB:AMLS) announced today that delays resulting from workload in the office of its auditors, Moen and Company, will result in...
Amersin Subsidiary Makes Application to State Food and Drug Administration For New Antiviral Drug License
12 mai 2005 10h38 HE
|
Amersin Life Sciences Corp.
NEW YORK, May 12, 2005 (PRIMEZONE) -- Amersin Life Science Corporation (OTCBB:AMLS) announced today that its subsidiary, Hubei Tongji Benda Ebei Pharmaceutical Co. (Hubei Benda), has applied to the...
Amersin Subsidiary Receives 30 Million RMB Contract
06 avr. 2005 09h00 HE
|
Amersin Life Sciences Corp.
NEW YORK, April 6, 2005 (PRIMEZONE) -- Amersin Life Science Corporation (OTCBB:AMLS) announced today that its subsidiary, Hubei Tongji Benda Ebei Pharmaceutical Company, has been awarded a 30 million...
Amersin Life Science Announces Appointment of Director
01 mars 2005 14h10 HE
|
Amersin Life Sciences Corp.
NEW YORK, March 1, 2005 (PRIMEZONE) -- Amersin Life Science Corporation (OTCBB:AMLS), is pleased to announce the appointment Mr. (Harry) Zhihao Jin to its board of directors.
Mr. Harry Jin served...
Amersin Announces 30% Increase in Ribavirin Production to Meet Market Demand Following Recent Avian Flu Outbreaks in Asia
31 janv. 2005 06h00 HE
|
Amersin Life Sciences Corp.
NEW YORK, Jan. 31, 2005 (PRIMEZONE) -- Amersin Life Sciences Corporation (OTCBB:AMLS) announced today that its subsidiary, Hubei Tongji Benda Ebei Pharmaceutical Co. Ltd. (HBPharma), will increase...
Hubei Pharmaceutical Group Reports Second Quarter Operational Profit of $681,666
23 sept. 2004 09h00 HE
|
Amersin Life Sciences Corp.
NEW YORK, Sept. 23, 2004 (PRIMEZONE) --
---------------------------------------------------------------------
Operational Results Second Quarter Six Months
at a Glance ...
Hubei Pharmaceutical Group to Sell Joint Venture Interest
14 sept. 2004 13h09 HE
|
Amersin Life Sciences Corp.
NEW YORK, Sept. 14, 2004 (PRIMEZONE) -- Hubei Pharmaceutical Group (OTCBB:HBEI) filed notice with the SEC today that it will sell its joint venture interest in Hubei Pharmaceutical Co. Ltd....